Medidata Solutions, Inc. (a Dassault Systèmes company)

Medidata is a leading cloud-based clinical trial management platform owned by Dassault Systèmes. The company provides an integrated software suite that connects patient, data, and study experiences across the entire clinical research lifecycle. The platform leverages AI and automation to streamline clinical trial operations, including patient engagement, electronic data capture, data management, regulatory submissions, and study oversight. Medidata's solutions serve pharmaceutical sponsors, contract research organizations (CROs), and clinical research sites globally. The platform has been used in over 100,000 clinical trials and processes billions of data points annually. Key capabilities include AI-driven study design and build automation, clinical data management with advanced analytics, real-time data quality monitoring, and patient experience tools designed to reduce burden and improve enrollment and retention. The company is trusted by major life sciences organizations and has achieved regulatory recognition, including FDA approval for novel drug submissions. Medidata operates as a Software-as-a-Service (SaaS) provider with a focus on accelerating clinical trial timelines, reducing costs, and improving data integrity. The platform integrates with existing clinical trial ecosystems and supports multi-study, multi-therapeutic area deployments.